✦ LIBER ✦

Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation

✍ Scribed by B. Degertekin; Steven-Huy B. Han; E. B. Keeffe; E. R. Schiff; V. A. Luketic; R. S. Brown; Jr.; S. Emre; C. Soldevila-Pico; K. R. Reddy; M. B. Ishitani; T. T. Tran; T. L. Pruett; A. S. F. Lok; the NIH HBV-OLT Study Group

Book ID: 114805524
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 274 KB
Volume: 10
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2010.03046.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intramuscular hepatitis B immunoglobulin

Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens

✍ Robert D Anderson; Srinath Chinnakotla; Linsheng Guo; Robert P Perrillo; Göran B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Prevention of recurrence of hepatitis B

Prevention of recurrence of hepatitis B after liver transplantation using HBIg with or without lamivudine

✍ P. Ciccorossi; F. Filipponi; A. Giannotti; F. Oliveri; B. Coco; P. Colombatto; F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Prophylaxis of hepatitis B reinfection a

Prophylaxis of hepatitis B reinfection after liver transplantation with hbig and lamivudine

✍ Rosenau, Jens; Bahr, Matthias J.; Tillmann, Hans L.; Klempnauer, Juergen; Manns, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Comparison of the efficacy in prevention

Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine

✍ K.W Lee; S.K Lee; J.W Joh; S.J Kim; J.H Park; S.E Chon; S.H Choi; J.S Heo; S.W P 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Factors associated with viral breakthrou

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation

✍ Henry Lik-Yuen Chan; Albert Ka-Keung Chui; Wan-Yee Lau; Francis Ka-Leung Chan; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

This study aimed to investigate the factors associated with viral breakthrough among liver transplant recipients who receive lamivudine monoprophylaxis. Consecutive patients receiving liver transplantation for HBV-related liver disease from June 1999 to October 2000 were studied. All patients receiv

Prophylaxis of hepatitis B recurrence af

Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin

✍ S Engler; P Sauer; E Klar; W Stremmel; B Kallinowski 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 57 KB